Steve Van Wormer 12/9/25 Steve Van Wormer 12/9/25

Best Practices for Managing Cough in PAH Patients Receiving Inhaled Therapies.

I’m Aware That I’m Rare: the phaware® podcast
Episode 550 - Jennifer Keeley, DPN and Mary Whittenhall, MSN

Jennifer Keeley and Mary Whittenhall, experienced nurse practitioners in the field of pulmonary hypertension, discuss the management of cough in patients receiving inhaled therapies for pulmonary hypertension and interstitial lung disease.

Steve Van Wormer 11/25/25 Steve Van Wormer 11/25/25

Scars and Survival: Rebuilding Life After a Devastating Diagnosis

I’m Aware That I’m Rare: the phaware® podcast
Episode 548 - Sophia Esteves

After countless hospital stays, new medications, and near-breaking points, Sophia Esteves found the reason she wanted to live — and it wasn’t just for herself. This episode dives into her spiritual and emotional transformation from patient to powerhouse advocate, and how she now helps others reclaim hope through honesty and grit.

Steve Van Wormer 6/2/25 Steve Van Wormer 6/2/25

YUTREPIA: A New FDA Approved Treatment for PAH & PH-ILD

I’m Aware That I’m Rare: the phaware® podcast
Episode 523 - Rodolfo Estrada, MD

Dr. Rodolfo Estrada, is a seasoned pulmonologists currently at UT Health San Antonio with significant experience in the management of patients with different forms of pulmonary hypertension. In this episode Dr. Estrada will discuss the technology and clinical development behind YUTREPIA™ (treprostinil) inhalation powder and why it might be a good option for some PAH and PH-ILD patients.

Steve Van Wormer 5/19/25 Steve Van Wormer 5/19/25

Clinical Trials: Pushing the Field Forward in PH-ILD

I’m Aware That I’m Rare: the phaware® podcast
Episode 521 - Jean Elwing, MD

Dr. Jean Elwing, a leading expert in pulmonary hypertension, discusses groundbreaking advancements in treating pulmonary hypertension associated with interstitial lung disease (PH-ILD). For years, patients with this condition had limited treatment options beyond oxygen therapy and symptom management. However, recent studies have introduced new hope, showing improved patient outcomes and quality of life. Dr. Elwing emphasizes the importance of early diagnosis, ongoing research, and clinical trial participation in pushing the field forward.

Steve Van Wormer 5/12/25 Steve Van Wormer 5/12/25

The Evolution of Inhaled Therapies: PRINT® Technology

I’m Aware That I’m Rare: the phaware® podcast
Episode 520 - Seth Hall, MBA, RRT

Seth Hall, MBA, RRT, takes listeners on a journey through the past, present, and future of inhaled therapies. Discover how these treatments have evolved, the life-changing benefits they offer, and the revolutionary technologies that could redefine outcomes for PAH and PH-ILD patients.

Steve Van Wormer 5/5/25 Steve Van Wormer 5/5/25

PH-ILD Breakthroughs: New Therapies Changing Lives

I’m Aware That I’m Rare: the phaware® podcast
Episode 519 - Richard Channick, MD

Dr. Richard Channick, dives into the evolving world within pulmonary hypertension - interstitial lung disease (PH-ILD). He sheds light on why early diagnosis matters and how new therapies are transforming care. Learn about the latest FDA-approved treatment and what’s on the horizon.

Steve Van Wormer 4/28/25 Steve Van Wormer 4/28/25

A New Era in PH-ILD Treatment and Research

I’m Aware That I’m Rare: the phaware® podcast
Episode 518 - Ioana Preston, MD

Dr. Ioana Preston explores the emerging field of pulmonary hypertension associated with interstitial lung disease (PH-ILD). She discusses the growing recognition of PH-ILD, especially after the introduction of inhaled treprostinil as a treatment, and highlights the importance of early screening and diagnosis. Dr. Preston also delves into the challenges of treating rare diseases, the evolution of research, and the hope for future therapies that could significantly improve patients’ lives. This insightful conversation sheds light on a critical yet often overlooked aspect of pulmonary care, urging clinicians to stay vigilant and informed about PH-ILD’s complexities.

Steve Van Wormer 4/14/25 Steve Van Wormer 4/14/25

Redefining PAH Treatment: The Next Frontier in Medicine

I’m Aware That I’m Rare: the phaware® podcast
Episode 516 - Ron Zolty, MD

Dr. Ron Zolty delves into groundbreaking advancements in treating pulmonary arterial hypertension. From the historical use of vasodilators to the revolutionary promise of sotatercept and seralutinib, Dr. Zolty unpacks how science is moving closer to halting - and possibly even reversing - PAH.personalized treatment approaches.

Steve Van Wormer 4/7/25 Steve Van Wormer 4/7/25

The Future of Pulmonary Hypertension Treatment

I’m Aware That I’m Rare: the phaware® podcast
Episode 515 - Rajan Saggar, MD

For decades, researchers have sought better treatments for pulmonary hypertension in interstitial lung disease, a condition that drastically impacts patients’ quality of life. In this episode, Dr. Rajan Saggar dives into the latest advancements, including new inhaled medications, upcoming clinical trials, and the push for more personalized treatment approaches.

I’m Aware That I’m Rare: the phaware® podcastEpisode 550 - Jennifer Keeley, DPN and Mary Whittenhall, MSN

I’m Aware That I’m Rare: the phaware® podcastEpisode 548 - Sophia Esteves

I’m Aware That I’m Rare: the phaware® podcastEpisode 523 - Rodolfo Estrada, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 521 - Jean Elwing, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 520 - Seth Hall, MBA, RRT

I’m Aware That I’m Rare: the phaware® podcastEpisode 519 - Richard Channick, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 518 - Ioana Preston, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 516 - Ron Zolty, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 515 - Rajan Saggar, MD